The Lung Cancer Assembly aims to develop and share new knowledge, facilitate and provide training opportunities and education for members to increase their expertise in all aspects of research and clinical practice in the field of lung cancer.
Current Assembly hot topics are screening and early detection of lung cancer, novel diagnostic bronchoscopic techniques, precision in lung cancer staging, genomic and molecular subtyping of lung cancer, circulating tumour biomarkers, molecular targeted therapies and immunotherapies.
The current Assembly Head, Prof. Liam, is interested in molecular targeted therapy and lung cancer immuno-oncology; the Head-Elect, Dr Stone, focuses on early diagnosis and screening, tobacco control and cessation, and survivorship issues; while the Deputy Head, Dr Andarini, is interested in molecular targeted therapy and immunotherapy.
We are happy to discuss the diagnosis and treatment of lung cancer, to clarify the epidemiology of lung cancer among Asian countries, to disseminate information on the latest edition of lung cancer staging and new treatment modalities for lung cancer to members of APSR.
The Assembly welcomes the participation of younger APSR members keen to develop knowledge, establish contacts and networks, present research ideas, seek training contacts and apply for funds. Senior members of APSR with vast experience are urged to join the Assembly to share their knowledge, train and educate the next generation, build research collaborations and to represent the Assembly on international projects with Sister Societies. Last but not least, the Assembly wishes to meet all APSR members who are keen to submit ideas for talks and presentations at future APSR Annual Congress Assembly Symposia.